Verdad Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
5,384
-34
-0.6% -$7.92K 1.31% 14
2026
Q1
$1.32M Sell
5,418
-11,990
-69% -$2.79M 1.49% 12
2025
Q4
$3.6M Buy
+17,408
New +$3.44M 4.12% 3
2024
Q3
$838K Buy
5,171
+363
+8% +$57.8K 1.12% 25
2024
Q2
$703K Buy
4,808
+1,883
+64% +$280K 0.81% 44
2024
Q1
$463K Buy
+2,925
New +$466K 0.5% 75

Other funds holding JNJ

Verdad Advisers's JNJ Position: Q2 2026 in Review

Verdad Advisers reduced its Johnson & Johnson (JNJ) stake by 0.63% in Q2 2026, selling an estimated $7.92K and leaving 5,384 shares worth $1.37M. The position accounts for 1.31% of the portfolio, ranked #14.

Verdad Advisers first reported a position in JNJ in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.6M in Q4 2025. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Verdad Advisers held 5,384 shares of Johnson & Johnson worth $1.37M as of Q2 2026.
  • Verdad Advisers sold 34 Johnson & Johnson shares in Q2 2026, an estimated $7.92K.
  • Johnson & Johnson made up 1.31% of Verdad Advisers's portfolio in Q2 2026, its #14 holding.
  • Verdad Advisers first reported a position in Johnson & Johnson in Q1 2024 and has held it in 6 quarters since.
  • Verdad Advisers's Johnson & Johnson position peaked at $3.6M in Q4 2025.
  • 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.